Table 1. The main pharmacokinetic parameters of NPPA-PTX and PTX after intravenous administration of the NPPAPTX (equimolar with 5 mg/kg PTX) and Taxol (PTX 5 mg/kg) in rats (mean ± S.D., n = 5).
Parameters | Unit | PTX | NPPA-PTX |
---|---|---|---|
Cmax | μM | 6.2±0.6 | 6.7±0.8 |
AUC(0-14) | μM*h | 6.0±0.5 | 18.5±1.5** |
AUC0-inf | μM*h | 6.6±0.4 | 40.1±9.8** |
t1/2 | h | 4.6±1.0 | 24.4±9.6** |
MRT(0-14) | h | 3.0±0.2 | 3.9±0.2** |
MRT0-inf | h | 4.9±0.5 | 28.6±11.4** |
p<0.01 vs PTX group